EN
DE
FR
Featured
A Guide to Anti-Money Laundering for Crypto Firms
5AMLD: High Value Goods
5MLD expands the scope of legislation regarding other stores of value: art traders, for example, or those acting as intermediaries, now have AML/CFT reporting obligations and will have to perform due diligence procedures on customers. The directive specifically singles out high value works of art for the first time, by applying regulation to transactions involving art which amount to €10,000 or more. 
The scope of 5MLD is not limited to art: now, transactions involving a range of high value goods are considered high risk – including oil, arms, precious metals, and tobacco. Notably, historical, cultural and archaeological artifacts are included in the regulation – a move to specifically target funding for terrorist groups such as ISIS.
Our AML solutions will help you remain compliant with the most up to date AML regulations.
5AMLD: High Value Goods
5MLD expands the scope of legislation regarding other stores of value: art traders, for example, or those acting as intermediaries, now have AML/CFT reporting obligations and will have to perform due diligence procedures on customers. The directive specifically singles out high value works of art for the first time, by applying regulation to transactions involving art which amount to €10,000 or more. The scope of 5MLD is not limited to art: now, transactions involving a range of high value goods are considered high risk - including oil, arms, precious metals, and tobacco. Notably, historical, cultural and archaeological artifacts are included in the regulation - a move to specifically target funding for terrorist groups such as ISIS.
Our AML solutions will help you remain compliant with the most up to date AML regulations.
Originally published September 6, 2018, updated May 5, 2022
Related Content
Featured
Disclaimer: This is for general information only. The information presented does not constitute legal advice. ComplyAdvantage accepts no responsibility for any information contained herein and disclaims and excludes any liability in respect of the contents or for action taken based on this information.
Copyright © 2022 IVXS UK Limited (trading as ComplyAdvantage).